1-20 of 141
Mario Tiribelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First report of the GIMEMA INO-first multicenter observational study analyzing infective and non-infective complications in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with inotuzumab ozogamicin.

Free
Anna Candoni, Alfonso Piciocchi, Luana Fianchi, Valeria Sargentini, Nicola Stefano Fracchiolla, Giovanni Marsili, Mario Tiribelli, Chiara Cattaneo, Cristina Papayannidis, Crescenza Pasciolla, Angelo Michele Carella, Massimiliano Bonifacio, Maria Ilaria Del Principe, Francesca Farina, Maria Paola Martelli, Monica Fumagalli, Nicola Di Renzo, Francesco Marchesi, Agostino Tafuri, Claudia Maria Basilico, Cristina Skert, Alessandro Busca, Livio Pagano
Journal: Blood
Blood (2025) 146 (Supplement 1): 5102.
https://doi.org/10.1182/blood-2025-5102
Published: 2025
Journal Articles

Ropeginterferon alfa-2b in 248 patients with polycythemia vera: Results from the italian cohort of a prospective, non-interventional, post-authorization study (ROPEG-PV)

Free
Tiziano Barbui, Arianna Ghirardi, Francesca Fenili, Fabrizio Pane, Giuseppe Palumbo, Alessandra Iurlo, Valerio De Stefano, Marco Santoro, Alessandro Rambaldi, Massimiliano Bonifacio, Elena Maria Elli, Francesca Lunghi, Alessandro Allegra, Elisa Rumi, Davide Rapezzi, Andrea Patriarca, Monia Marchetti, Massimo Breccia, Rossella Stella, Giuseppe Carli, Rosa Daffini, Mario Tiribelli, Antonio Cuneo, Sara Galimberti, Giulia Benevolo, Francesca Palandri, Alessandra Ricco, Marianna Caramella, Irene Bertozzi, Angelo Michele Carella, Alessandro Maria Vannucchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 5572.
https://doi.org/10.1182/blood-2025-5572
Published: 2025
Journal Articles

It's not yet time to abandon ruxolitinib in anemic myelofibrosis: Predictive factors of erythroid response to standard anemia-directed therapies combined with ruxolitinib

Free
Massimiliano Bonifacio, Alda Strazimiri, Giuseppe Carli, Luigi Scaffidi, Gessica Marchesini, Ilaria Nichele, Gian Luca Morelli, Melissa Bergnach, Luca Tosoni, Renato Fanin, Alberto Tosetto, Mauro Krampera, Mario Tiribelli
Journal: Blood
Blood (2025) 146 (Supplement 1): 3820.
https://doi.org/10.1182/blood-2025-3820
Published: 2025
Journal Articles

Prognostic impact of persistent and treatment-emergent cytopenia in 879 myelofibrosis patients treated with ruxolitinib: The “RUX-MF” study

Free
Francesca Palandri, Filippo Branzanti, Massimiliano Bonifacio, Elena Maria Elli, Elisabetta Abruzzese, Erika Morsia, Mirko Farina, Mario Tiribelli, Giulia Benevolo, Eloise Beggiato, Bruno Martino, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Alessandra Iurlo, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Andrea Duminuco, Daniele Cattaneo, Roberto Lemoli, Costanza Bosi, Monica Bocchia, Fabrizio Pane, Chiara Sartor, Florian Heidel, Massimo Breccia, Giuseppe Palumbo
Journal: Blood
Blood (2025) 146 (Supplement 1): 3806.
https://doi.org/10.1182/blood-2025-3806
Published: 2025
Journal Articles

Trial in progress: A study of roginolisib in combination with ruxolitinib in patients with myelofibrosis who are unresponsive to JAK inhibitors (HEMA-MED)

Free
Alessandro Vannucchi, Chiara Paoli, Paola Guglielmelli, Michael Lahn, Giusy Di Conza, Tracey Hammett, Paramjit Kaur, Jasson Villarreal Hernandez, Mario Tiribelli, Armando Santoro, Matteo Della Porta
Journal: Blood
Blood (2025) 146 (Supplement 1): 3797.
https://doi.org/10.1182/blood-2025-3797
Published: 2025
Journal Articles

A pre-emptive bridge-to-transplant therapy for measurable residual disease with venetoclax and azacitidine in NPM1-mutated Acute Myeloid Leukemia: Updates from the ongoing GIMEMA AML2521 phase 2 trial

Free
Chiara Sartor, Anna Candoni, Alfonso Piciocchi, Giovanni Marsili, Paola Fazi, Cristina Papayannidis, Jacopo Nanni, Stefania Paolini, Luca Maurillo, Mario Tiribelli, Antonino Mule', Melissa Campanelli, Marianna Norata, Roberto Cairoli, Emanuela Ottaviani, Giulia Azteni, Maria Teresa Voso, Francesca Bonifazi, Enrico Maffini, Lorenzo Brunetti, Cristina Skert, Francesco Di Raimondo, Roberto Lemoli, Pellegrino Musto, Maria Paola Martelli, Brunangelo Falini, Adriano Venditti, Francesco Buccisano, Antonio Curti
Journal: Blood
Blood (2025) 146 (Supplement 1): 3516.
https://doi.org/10.1182/blood-2025-3516
Published: 2025
Journal Articles

Up-front blinatumomab improves MRD clearance and outcome in adult Ph – B-lineage ALL: the GIMEMA LAL2317 phase 2 study

Available to Purchase
Clinical Trials & Observations
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Alessandra Santoro, Orietta Spinelli, Manuela Tosi, Loredana Elia, Deborah Cardinali, Maria Stefania De Propris, Matteo Piccini, Federico Lussana, Mario Annunziata, Patrizia Chiusolo, Patrizia Zappasodi, Erika Borlenghi, Matteo Leoncin, Catello Califano, Monica Bocchia, Francesco Di Raimondo, Francesco Grimaldi, Mario Tiribelli, Anna Candoni, Albana Lico, Ernesta Audisio, Monia Lunghi, Anna Maria Mianulli, Mariangela Di Trani, Valentina Arena, Monica Messina, Alfonso Piciocchi, Paola Fazi, Alessandro Rambaldi, Robin Foà
Journal: Blood
Blood (2025) 145 (21): 2447–2459.
https://doi.org/10.1182/blood.2024027500
Published: 2025
Includes: Supplemental data
Journal Articles

CML Patients Who Fail to Achieve ≤ 1% BCR::ABL1 at 12 Months or ≤ 0.1% BCR::ABL1 at 24 Months (major molecular response, MMR) Show Significantly Inferior Survival, but Not Due to CML-Related Deaths: Data from an Italian Real-Life Observational Study

Free
Valentina Giai, Tiziana Rosso, Fausto Castagnetti, Patrizia Pregno, Massimiliano Bonifacio, Isabella Capodanno, Mario Tiribelli, Fabio Stagno, Giovanni Caocci, Antonella Gozzini, Luigiana Luciano, Sara Galimberti, Monica Bocchia, Andrea Patriarca, Giuseppe Lanzarone, Bruno Martino, Anna Guella, Anna Rita Scortechini, Carmen Fava, Claudio Fozza, Simona Sica, Nicola Di Renzo, Pellegrino Musto, Domenico Pastore, Alessandro Maggi, Michele Pizzuti, Lorella Maria Antonia Melillo, Angelo Michele Carella, Giuseppe Tarantini, Anna Mele, Elisabetta Calistri, Maria Rosaria Coppi, Fabio Saccona, Emilia Scalzulli, Beatrice Battaglio, Miriam Iezza, Cinzia Bitetti, Roberto Freilone, Gianantonio Rosti, Francesco Albano, Fabrizio Pane, Giorgina Specchia, Massimo Breccia, Giovannino Ciccone, Giuseppe Saglio
Journal: Blood
Blood (2024) 144 (Supplement 1): 3155.
https://doi.org/10.1182/blood-2024-207877
Published: 2024
Journal Articles

Probability of Switch of TKIs Treatment According to Baseline Features in a Large Chronic Myeloid Leukemia (CML) Population: Italian CML Network

Free
Massimo Breccia, Valentina Giai, Tiziana Rosso, Patrizia Pregno, Fausto Castagnetti, Massimiliano Bonifacio, Isabella Capodanno, Mario Tiribelli, Fabio Stagno, Olga Mulas, Antonella Gozzini, Luigiana Luciano, Sara Galimberti, Andrea Patriarca, Giuseppe Lanzarone, Bruno Martino, Anna Guella, Anna Rita Scortechini, Carmen Fava, Claudio Fozza, Federica Sorà, Alessandro Maggi, Michele Pizzuti, Sara Freducci, Giuseppina Loglisci, Antonella Russo Rossi, Maria Laura Di Noi, Giuseppina Spinosa, Maria Teresa Santeramo, Grazia Sanpaolo, Giuseppe Pietrantuono, Clara Mannarella, Elisabetta Calistri, Eleonora Prete, Gianantonio Rosti, Fabrizio Pane, Giuseppe Saglio, Giovannino Ciccone, Giorgina Specchia
Journal: Blood
Blood (2024) 144 (Supplement 1): 4535.
https://doi.org/10.1182/blood-2024-202477
Published: 2024
Journal Articles

Venetoclax and Azacitidine for Relapse Prevention in NPM1 -Mutated Acute Myeloid Leukemia in Molecular Failure: Results from the Ongoing Gimema AML2521 Phase 2 Trial

Free
Chiara Sartor, Anna Candoni, Alfonso Piciocchi, Giovanni Marsili, Paola Fazi, Cristina Papayannidis, Stefania Paolini, Gianluca Cristiano, Luca Maurillo, Mario Tiribelli, Antonino Mulè, Melissa Campanelli, Giovanni Marconi, Paola Minetto, Emanuela Ottaviani, Maria Teresa Voso, Francesca Bonifazi, Attilio Olivieri, Pellegrino Musto, Francesco Di Raimondo, Roberto Massimo Lemoli, Maria Paola Martelli, Brunangelo Falini, Michele Cavo, Adriano Venditti, Francesco Buccisano, Antonio Curti
Journal: Blood
Blood (2024) 144 (Supplement 1): 2893.
https://doi.org/10.1182/blood-2024-210315
Published: 2024
Journal Articles

Cytopenias and Failure to Use Innovative Therapy Are Main Drivers of Worse Outcome after Discontinuation of Ruxolitinib in Myelofibrosis

Free
Francesca Palandri, Massimo Breccia, Erika Morsia, Giulia Benevolo, Mario Tiribelli, Eloise Beggiato, Mirko Farina, Bruno Martino, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Elisabetta Abruzzese, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Alessia Moioli, Veronica Guglielmana, Santino Caserta, Andrea Duminuco, Roberto Massimo Lemoli, Daniela Cilloni, Monica Bocchia, Fabrizio Pane, Florian Heidel, Elena Maria Elli, Massimiliano Bonifacio, Giuseppe Alberto Palumbo, Filippo Branzanti
Journal: Blood
Blood (2024) 144 (Supplement 1): 6664.
https://doi.org/10.1182/blood-2024-199961
Published: 2024
Journal Articles

Baseline Features, Treatment Choice and Early Frontline TKI Permanent Discontinuation in Patients with Newly Diagnosed Chronic Myeloid Leukemia Aged 50 - 60 Years: A “Campus CML” Study

Free
Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Atelda Romano, Federica Sorà, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Francesco Cavazzini, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Marco Santoro, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Michele Pizzuti, Alessandra Iurlo, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 1772.
https://doi.org/10.1182/blood-2024-207175
Published: 2024
Journal Articles

ASXL1 Mutations at Diagnosis Did Not Impact on the Depth of Molecular Response (MR) and on Treatment-Free Remission (TFR) Eligibility in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Receiving either Nilotinib (NIL) First-Line or Imatinib (IM) with Early Switch to NIL in Case of No Optimal Response in the SUSTRENIM Clinical Trial

Free
Simona Soverini, Sara De Santis, Cecilia Monaldi, Manuela Mancini, Valentina Giai, Marco Cerrano, Isabella Capodanno, Massimiliano Bonifacio, Elisabetta Abruzzese, Alessandra Iurlo, Fausto Castagnetti, Rosaria Sancetta, Luciano Levato, Carmen Fava, Mario Tiribelli, Francesco Cavazzini, Maria Cristina Miggiano, Niccolò Bolli, Agostino Tafuri, Alessandro Lucchesi, Daniele Vallisa, Monia Lunghi, Caterina Musolino, Samantha Bruno, Cristina Mosca, Mauro Ciriello, Giovanni Marsili, Alfonso Piciocchi, Paola Fazi, Michele Cavo, Jeroen J.W.M. Janssen, Peter E. Westerweel, Fabrizio Pane
Journal: Blood
Blood (2024) 144 (Supplement 1): 3158.
https://doi.org/10.1182/blood-2024-205465
Published: 2024
Journal Articles

Personalized Transplant Decision Making for Myelofibrosis in the Era of Molecular Genetics and JAK Inhibition

Free
Nico Gagelmann, Barbara Mora, Filippo Branzanti, Alessandro Maria Vannucchi, Massimo Breccia, Giuseppe Alberto Maria Palumbo, Massimiliano Bonifacio, Erika Morsia, Elena Maria Elli, Mario Tiribelli, Giulia Benevolo, Mirko Farina, Fabrizio Pane, Roberto Massimo Lemoli, Giovanni Caocci, Alessia Tieghi, Gianni Binotto, Francesco Cavazzini, Bruno Martino, Alessandro Isidori, Margherita Maffioli, Elisa Rumi, Tiziano Barbui, Francisco Cervantes, Matteo Giovanni Della Porta, Andrew T. Kuykendall, Marianna Caramella, Alessandra Iurlo, Valerio De Stefano, Jean-Jacques Kiladjian, David Ross, Jason Gotlib, Timothy Devos, Marco Ruggeri, Richard T. Silver, Rachel B. Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Christina Rautenberg, Marie Robin, Marie-Thérèse Rubio, Jaroslaw Maciejewski, Alessandro Rambaldi, Maria Chiara Finazzi, Andrea Bacigalupo, Patrizia Chiusolo, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kröger, Francesco Passamonti, Francesca Palandri
Journal: Blood
Blood (2024) 144 (Supplement 1): 245.
https://doi.org/10.1182/blood-2024-210804
Published: 2024
Journal Articles

Revised ELN Criteria in Polycythemia Vera Identify an Increased Risk Phenotype for Thrombotic Events Beyond Conventional Risk Stratification. a Multicenter Cooperative Study

Free
Francesca Palandri, Elena Maria Elli, Giulia Benevolo, Alessandra Dedola, Roberto Latagliata, Erika Morsia, Mario Tiribelli, Francesco Cavazzini, Alessia Tieghi, Mirko Farina, Alessandra D'Addio, Elisabetta Abruzzese, Fabrizio Cavalca, Rikard Mullai, Antonio Cuneo, Bruno Martino, Florian Heidel, Elena Rossi, Massimo Breccia, Valerio De Stefano, Filippo Branzanti
Journal: Blood
Blood (2024) 144 (Supplement 1): 242.
https://doi.org/10.1182/blood-2024-200528
Published: 2024
Journal Articles

Efficacy of Venetoclax-Based Therapy Followed By Allogeneic Transplantation in Newly Diagnosed and Relapsed/Refractory AML Patients

Free
Matteo Fanin, Davide Lazzarotto, Alessandra Sperotto, Ilaria Tanasi, Matteo Leoncin, Carmela Gurrieri, Carla Fili, Chiara Callegari, Giulia Battaglia, Erica Simeone, Maria Elena Zannier, Luca Tosoni, Gian Luca Morelli, Melissa Bergnach, Michele Gottardi, Edoardo Tamellini, Sara Consolo, Cristina Skert, Francesco Angotzi, Federica Lessi, Mauro Krampera, Francesca Patriarca, Daniela Damiani, Renato Fanin, Mario Tiribelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 6038.
https://doi.org/10.1182/blood-2024-205250
Published: 2024
Journal Articles

Efficacy of Frontline Treatment with Initial Low-Dose Tyrosine-Kinase Inhibitors in Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study

Free
Cristina Bucelli, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Mario Annunziata, Federica SORA, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Imma Attolico, Gianni Binotto, Elena Crisa', Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Rosaria Sancetta, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, Roberto Latagliata
Journal: Blood
Blood (2023) 142 (Supplement 1): 3176.
https://doi.org/10.1182/blood-2023-186406
Published: 2023
Journal Articles

The Use of 2 nd Generation TKIs As First Line Therapy Does Not Prevent CML Related Deaths: Results of an Italian CML Campus Prospective Study in 1277 Patients Treated First Line with Imatinib or 2 nd Generation TKIs

Free
Valentina Giai, Fabio Stagno, Tiziana Rosso, Fausto Castagnetti, Isabella Capodanno, Massimiliano Bonifacio, Mario Tiribelli, Sara Galimberti, Monica Bocchia, Antonella Gozzini, Giovanni Caocci, Andrea Patriarca, Giuseppe Lanzarone, Anna Guella, Federica Sorà, Luigiana Luciano, Anna Rita Scortechini, Nicola Di Renzo, Pellegrino Musto, Domenico Pastore, Alessandro Maggi, Carmen Fava, Vincenzo Pavone, Claudio Fozza, Giuseppina Spinosa, Angelo Michele Carella, Giuseppe Tarantini, Bruno Martino, Michele Pizzuti, Clara Mannarella, Fabio Saccona, Gianantonio Rosti, Patrizia Pregno, Massimo Breccia, Fabrizio Pane, Giovannino Ciccone, Giorgina Specchia, Giuseppe Saglio
Journal: Blood
Blood (2023) 142 (Supplement 1): 3168.
https://doi.org/10.1182/blood-2023-182981
Published: 2023
Journal Articles

3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients

Free
Michele Malagola, Alessandra Iurlo, Cristina Bucelli, Elisabetta Abruzzese, Massimiliano Bonifacio, Fabio Stagno, Gianni Binotto, Mariella D'Adda, Monia Lunghi, Monica Crugnola, Maria Luisa Ferrari, Francesca Lunghi, Fausto Castagnetti, Gianantonio Rosti, Roberto Massimo Lemoli, Rosaria Sancetta, Maria Rosaria Coppi, Maria Teresa Corsetti, Matteo Dalmazzo, Atelda Romano, Mario Tiribelli, Antonella Russo Rossi, Sabina Russo, Anna Sicuranza, Aldo Roccaro, Giulia Butturini, Mirko Farina, Simona Bernardi, Simone Pellizzeri, Nicola Polverelli, Domenico Russo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3165.
https://doi.org/10.1182/blood-2023-177619
Published: 2023
Journal Articles

ELN Criteria for Cytoreduction Start Identify Patients with Polycythemia Vera at Higher Thrombotic Risk

Free
Francesca Palandri, Giulia Benevolo, Elena Maria Elli, Roberto Latagliata, Giuseppe Auteri, Filippo Branzanti, Mario Tiribelli, Francesco Cavazzini, Alessia Tieghi, Nicola Polverelli, Alessandra D'Addio, Elisabetta Abruzzese, Federica Colombo, Marta Venturi, Francesco Ramundo, Rikard Mullai, Antonio Cuneo, Benedetto Bruno, Michele Cavo, Giuseppe Alberto Palumbo, Florian H Heidel, Massimo Breccia, Valerio De Stefano
Journal: Blood
Blood (2023) 142 (Supplement 1): 4527.
https://doi.org/10.1182/blood-2023-181553
Published: 2023